Co-crystals and salts of CCR3-inhibitors

US9233950B2 · kind B2 · utility

Assignee

• Boehringer Ingelheim International GmbH · DE

Inventors

• Markus Frank · Baden-Baden, DE
• Hans Haeberle · Maselheim, DE
• Manuel HENRY · Schemmerhofen, DE
• Thorsten Pachur · Biberach an der Riß, DE
• Marco Santagostino · Magenta, IT
• Uwe Stertz · Biberach an der Riß, DE
• Thomas Trebing · Biberach an der Riß, DE
• Ulrike Werthmann · Biberach an der Riß, DE

Key dates

• Filing date: Dec 17, 2014
• Grant date: Jan 12, 2016
• Expiry date: Dec 17, 2034

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D401/04
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

This invention relates to co-crystals and salts of CCR3 inhibitors of formula 1,pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of diseases related with the CCR3-receptor.